Suat Utku Keskin

Dr. Suat Utku Keskin


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2026 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
NYNurcan Yoruk
Nurcan Yoruk
NMNuray Bayar Muluk
Nuray Bayar Muluk
ŞDŞeyma Nur Dere
Şeyma Nur Dere
TATalat Yasin Acar
Talat Yasin Acar
SKSuat Utku Keskin
Suat Utku Keskin
CCCemal Cingi
Cemal Cingi
Objectives: The antioxidant, anti-inflammatory, and skin-protective characteristics of aloin, a bioactive anthraquinone glycoside extracted from Aloe vera, have garnered significant interest. Its compatibility with dermal fibroblasts is an important prerequisite for its use in wound-healing formulations. To establish a safe in vitro concentration range for future wound-healing research, this work assessed the cytotoxic effects of aloin on primary human dermal fibroblast cells, which vary with concentration. Methods: We cultured primary human adult dermal fibroblasts (HDFa) according to standard protocols after obtaining them from ATCC. Various concentrations of aloin (10, 25, 50, 100, 150, and 200 µM) were applied to the cells. The MTT colorimetric test was used to determine the cell viability. A positive cytotoxic control was used with Triton X-100, whereas untreated cells grown in DMEM served as the negative control. The statistical analyses were carried out using GraphPad Prism 10, namely one-way ANOVA and nonlinear regression analysis. Results: No concentration of aloin treatment significantly decreased fibroblast vitality compared with the control group ( P >0.05). The lack of a concentration-dependent cytotoxic response was demonstrated by nonlinear regression analysis up to 200 µM. Triton X-100, in contrast, significantly reduced cell viability, thereby demonstrating the assay's experimental validity and sensitivity. Conclusion: In vitro biocompatibility studies with primary human dermal fibroblasts showed that aloin was very safe and did not cause cytotoxicity at the concentrations considered. Based on these results, aloin appears to be a good choice for future preclinical research on skin regeneration and wound healing.

11 December 2025 in Journal of Craniofacial Surgery
Verified
Journal Article
Open access
ZÖZeynel Öztürk
Zeynel Öztürk
NMNuray Bayar Muluk
Nuray Bayar Muluk
SKSuat Utku Keskin
Suat Utku Keskin
MBMuhammet Volkan Bülbül
Muhammet Volkan Bülbül
EAELVIN ALASKAROV
ELVIN ALASKAROV
CCCemal Cingi
Cemal Cingi
Objectives: We investigated the cytotoxic effects of Mentha piperita oil on HNO210 human laryngeal cancer cells. Methods: Every experiment used BHC11100312, BioHippo, cryopreserved HNO210 human laryngeal cancer cells. The cells were cultured in a specific medium containing fetal bovine serum (10%; ATCC 30-2020™) and an antibiotic-antimycotic solution (1%; Gibco, 15240062). Mentha piperita oil was serially diluted to prepare solutions at final concentrations of 10, 50, 100, 150, 200, 250, and 500 µg/mL. The colorimetric MTT assay (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) was used to assess the antiproliferative effects. Results: A reduction in cell viability was observed after 24 hours of treatment with Mentha piperita oil, and this reduction was dose-dependent. At concentrations above 200 µg/mL, there was a clear cytotoxic response, with cell survival becoming nearly nonexistent. The growth and metabolic stability of HNO210 cells are significantly suppressed by M. piperita oil in vitro. The essential oil of Mentha piperita exhibits a strong cytotoxic effect on HNO210 cells, decreasing their metabolic activity and ability to proliferate after 24 hours of exposure. The treated cells showed obvious signs of cytoplasmic shrinkage, reduced cell density, and loss of intercellular connections. Membrane blebbing and partial detachment from the culture surface were also observed in the treated cultures, indicating cytotoxic stress and potential apoptotic events. Conclusions: Mentha piperita oil inhibits the vitality of HNO210 laryngeal cancer cells. It exhibits anticancer potential and has a concentration-dependent cytotoxic effect. The antiproliferative properties of Mentha piperita oil make it a promising candidate for developing effective cancer treatments.

Verified
Journal Article
Open access
PDF file
STSeval Tasdemir
Seval Tasdemir
MBMuhammet Volkan Bülbül
Muhammet Volkan Bülbül
BKBetul Kalay
Betul Kalay
MSMasite Sehadet Senol
Masite Sehadet Senol
STSafak Tavukcuoglu
Safak Tavukcuoglu
ESEge Can Serefoglu
Ege Can Serefoglu
Background: Melatonin concentrations in follicular fluid exceed serum levels, suggesting local ovarian accumulation and a potential role in the follicular microenvironment. Previous studies reporting associations between intrafollicular melatonin and IVF outcomes have largely relied on dominant-follicle sampling. This study evaluated pooled follicular-fluid melatonin concentrations across clinical ovarian-response phenotypes in women undergoing standardized melatonin-supplemented IVF-ICSI cycles. Methods: Seventy-one women undergoing controlled ovarian stimulation with a GnRH antagonist protocol were prospectively enrolled. All participants received oral melatonin at 3 mg/day) from gonadotropin initiation until oocyte retrieval. Participants were classified as poor (n = 24), normal (n = 22), or high responders (n = 25) using predefined clinical ovarian-response criteria. Pooled follicular fluid was collected during oocyte retrieval and melatonin was measured by ELISA. Age-adjusted and multivariable models were used to re-evaluate between-group melatonin differences, the AMH–melatonin association, and the relationship between melatonin and retrieved oocyte number. Results: In the unadjusted analysis, pooled follicular-fluid melatonin concentrations differed across ovarian -response groups (p = 0.0132), with lower levels in poor responders than in normal and high responders. This group effect remained after age adjustment (overall p = 0.0315), with higher concentrations in normal versus poor responders (β = 0.758, p = 0.0278) and high versus poor responders (β = 0.589, p = 0.0070). The age-adjusted AMH–melatonin association remained weakly positive (β = 0.174, 95% CI 0.022–0.327, p = 0.0250), but was no longer evident after conditioning on ovarian-response group (β = 0.011, 95% CI −0.350–0.372, p = 0.9534). In a negative-binomial model, melatonin was associated with retrieved oocyte number after age adjustment (IRR = 1.435, 95% CI 1.066–1.931, p = 0.0173), whereas the association was not retained in the exploratory group-conditioned model (IRR = 1.027, 95% CI 0.893–1.180, p = 0.7103). No consistent association was observed with downstream embryological outcomes. Conclusions: Under standardized melatonin supplementation, lower pooled follicular-fluid melatonin remained associated with the poor-response phenotype after age adjustment. However, the AMH–melatonin and melatonin–oocyte-yield associations were sensitive to the structure of the ovarian-response categories. These findings are observational and hypothesis-generating and do not establish a causal treatment effect, an independent ovarian-reserve biomarker relationship, or clinical utility.